Andrew C. Phillips

4.3k total citations · 2 hit papers
29 papers, 2.7k citations indexed

About

Andrew C. Phillips is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrew C. Phillips has authored 29 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrew C. Phillips's work include Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (6 papers) and HER2/EGFR in Cancer Research (6 papers). Andrew C. Phillips is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (6 papers) and HER2/EGFR in Cancer Research (6 papers). Andrew C. Phillips collaborates with scholars based in United States, Australia and United Kingdom. Andrew C. Phillips's co-authors include Karen H. Vousden, Kevin M. Ryan, Stewart Bates, Meredith S. Irwin, Elsa R. Flores, Jeremy C. Smith, Tyler Jacks, Wanguo Liu, Kenneth Y. Tsai and María C. Marín and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Andrew C. Phillips

29 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role for the p53 homologue p73 in E2F-1-induced apoptosis

2000 592 citations Meredith S. Irwin, María C. Marín et al. Nature profile →
Regulation and function of the p53 tumor suppressor protein

2001 591 citations Kevin M. Ryan, Andrew C. Phillips et al. Current Opinion in Cell Biology profile →

Peers

Countries citing papers authored by Andrew C. Phillips

Since Specialization

Citations

This map shows the geographic impact of Andrew C. Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew C. Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew C. Phillips more than expected).

Fields of papers citing papers by Andrew C. Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew C. Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew C. Phillips. The network helps show where Andrew C. Phillips may publish in the future.

Co-authorship network of co-authors of Andrew C. Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew C. Phillips. A scholar is included among the top collaborators of Andrew C. Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew C. Phillips. Andrew C. Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MO38-1 Phase 1 study of ABBV-155 ± paclitaxel in relapsed/refractory solid tumors: Results in Japanese patients 2023 ·Annals of Oncology ·Toshio Shimizu, Kan Yonemori, Yasutoshi Kuboki, Anthony W. Tolcher, (unknown), Wijith Munasinghe, Andrew C. Phillips, Andrew J. Souers, Eric F. Johnson, Lei He, Aaron Weitzman, (unknown), Patricia LoRusso, Yoichi Naito	1
2	Abstract 6311: ABBV-400: An ADC delivering a novel topoisomerase 1 inhibitor to c-Met-positive solid tumors 2023 ·Cancer Research ·Regina M. Reilly, (unknown), (unknown), Mark G. Anderson, Lora A. Tucker, (unknown), (unknown), Erwin R. Boghaert, Marybeth A. Pysz, Aloma D’Souza, Laura M. Kreckler, Milan Bruncko, (unknown), Matthew M. Ravn, George Doherty, Kevin J. Freise, Andrew C. Phillips	7
3	1185TiP First-in-human phase I study of ABBV-637 as monotherapy and in combination in patients with relapsed and refractory solid tumors 2022 ·Annals of Oncology ·Julia Rotow, Kiyotaka Yoh, (unknown), (unknown), Ruth Perets, (unknown), Andrew C. Phillips, Andrew J. Souers, Peter Ansell, (unknown), Mohamed Badawi, (unknown), (unknown), Shawn Jeffries, (unknown), Benedito A. Carneiro, K. Papadopoulos	2
4	Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR 2021 ·Journal of Neuro-Oncology ·Kedar S. Vaidya, Michael J. Mitten, (unknown), Anatol Oleksijew, Cory Alvey, Hugh D. Falls, (unknown), Joann P. Palma, Peter Ansell, Andrew C. Phillips, Edward B. Reilly, Mark G. Anderson, Erwin R. Boghaert	9
5	Abstract 743: ABT-806-derived antibody-drug conjugates (ADCs) inhibit growth of malignant mesothelioma in vivo 2018 ·Cancer Research ·Puey Ling Chia, Diana Cao, Angela Rigopoulos, Hui Gan, (unknown), Andrew C. Phillips, Thomas John, Andrew M. Scott	1
6	ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope 2016 ·Molecular Cancer Therapeutics ·Andrew C. Phillips, Erwin R. Boghaert, Kedar S. Vaidya, Michael J. Mitten, Suzanne M. Norvell, Hugh D. Falls, Peter J. DeVries, Dong Cheng, Jonathan A. Meulbroek, Fritz G. Buchanan, Laura M. McKay, Neal Goodwin, Edward B. Reilly	136
7	Heat shock factor 1 deficiency via its downstream target gene αB‐crystallin (Hspb5) impairs p53 degradation 2009 ·Journal of Cellular Biochemistry ·Xiongjie Jin, Demetrius Moskophidis, Yanzhong Hu, Andrew C. Phillips, Nahid F. Mivechi	26
8	Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis 2008 ·Cancer Gene Therapy ·(unknown), Andrew C. Phillips	26
9	Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation 2007 ·Nucleic Acids Research ·Zheqiong Yang, Yang Sui, Shiqin Xiong, Sean S. Liour, Andrew C. Phillips, Lan Ko	24
10	Xaf1 can cooperate with TNFα in the induction of apoptosis, independently of interaction with XIAP 2006 ·Molecular and Cellular Biochemistry ·Yan Xia, (unknown), Jennifer A. Lewis, Colin S. Duckett, Andrew C. Phillips	44
11	Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells 2005 ·Cancer Cell ·Yili Yang, Robert L. Ludwig, Jane P. Jensen, (unknown), (unknown), Ilia V. Davydov, Yassamin J. Safiran, Pankaj Oberoi, John H. Kenten, Andrew C. Phillips, Allan M. Weissman, Karen H. Vousden	263
12	Regulation and function of the p53 tumor suppressor protein breakdown → 2001 ·Current Opinion in Cell Biology ·Kevin M. Ryan, Andrew C. Phillips, (unknown)	591
13	E2F-1 induced apoptosis 2001 ·APOPTOSIS ·Andrew C. Phillips, Karen H. Vousden	114
14	Role for the p53 homologue p73 in E2F-1-induced apoptosis breakdown → 2000 ·Nature ·Meredith S. Irwin, María C. Marín, Andrew C. Phillips, Ratnam S. Seelan, Jeremy C. Smith, Wanguo Liu, Elsa R. Flores, Kenneth Y. Tsai, Tyler Jacks, Karen H. Vousden, William G. Kaelin	592
15	Acetyltransferases and tumour suppression 2000 ·Breast Cancer Research ·Andrew C. Phillips, (unknown)	19
16	E2F-1 Potentiates Cell Death by Blocking Antiapoptotic Signaling Pathways 1999 ·Molecular Cell ·Andrew C. Phillips, Mary K. Ernst, Stewart Bates, Nancy R. Rice, Karen H. Vousden	204
17	Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression 1998 ·Oncogene ·Stewart Bates, Kevin M. Ryan, Andrew C. Phillips, Karen H. Vousden	149
18	Induction of DNA synthesis and apoptosis are separable functions of E2F-1. 1997 ·Genes & Development ·Andrew C. Phillips, Stewart Bates, Kevin M. Ryan, Kristian Helin, Karen H. Vousden	237
19	Analysis of the interaction between human papillomavirus type 16 E7 and the TATA-binding protein, TBP. 1997 ·Journal of General Virology ·Andrew C. Phillips, Karen H. Vousden	46
20	Development of an enzyme-linked immunosorbent assay for the detection and measurement of the trypanocidal drug isometamidium chloride in cattle 1991 ·Research in Veterinary Science ·D.D. Whitelaw, E. A. Gault, P.H. Holmes, I.A. Sutherland, F. J. Rowell, Andrew C. Phillips, G.M. Urquhart	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact